首页> 外文期刊>Neuropharmacology >Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress
【24h】

Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress

机译:PINK1的缺失增强了线粒体应激触发的帕金森氏病小鼠模型中的神经变性

获取原文
获取原文并翻译 | 示例
           

摘要

Parkinson's disease (PD) shows a complex etiology, where both genetic and environmental factors contribute to initiation and advance of pathology. Mitochondrial dysfunction and mutation of genes implicated in mitochondria quality control are recognized contributors to etiopathology and progression of PD. Here we report the development and characterization of a genetic mouse model of PD with a combined etiology comprising: 1) induction of mitochondrial stress achieved through the expression of a mitochondrial matrix protein that accumulates in an unfolded state and 2) deletion of PINK1 gene. Using this model we address the role of PINK1 in mitochondrial quality control and disease progression. To induce mitochondrial stress specifically in catecholaminergic neurons we generated transgenic animals where the conditional expression of mitochondrial unfolded ornithine transcarbamylase (dOTC) is achieved under the tyrosine hydroxylase (Th) promoter. The mice were characterized in terms of survival, growth and motor behaviour. The characterization was followed by analysis of cell death induced in dopaminergic neurons and responsiveness to l-dopa. We demonstrate that accumulation of dOTC in dopaminergic neurons causes neurodegeneration and motor behaviour impairment that illustrates a parkinsonian phenotype. This associates with l-dopa responsiveness validating the model as a model of PD. The combined transgenic model where dOTC is overexpressed in PINK1 KO background presents increased neurodegeneration as compared to dOTC transgenic in wild-type background. Moreover, this combined model does not show responsiveness to l-dopa. Our in vivo data show that loss of PINK1 accelerates neurodegenerative phenotypes induced by mitochondrial stress triggered by the expression of an unfolded protein in this organelle.
机译:帕金森氏病(PD)具有复杂的病因,遗传和环境因素均有助于病理的发生和发展。线粒体功能控制中涉及的线粒体功能障碍和基因突变被认为是PD的病因病理和进展的原因。在这里,我们报道具有组合病因的PD遗传小鼠模型的开发和表征,所述病因包括:1)通过表达处于折叠状态的线粒体基质蛋白的表达实现的线粒体应激诱导和2)PINK1基因的缺失。使用此模型,我们解决了PINK1在线粒体质量控制和疾病进展中的作用。为了在儿茶酚胺能神经元中特别诱导线粒体应激,我们生成了转基因动物,其中在酪氨酸羟化酶(Th)启动子下实现了线粒体折叠的鸟氨酸转氨甲酰酶(dOTC)的条件表达。根据存活,生长和运动行为来表征小鼠。在表征之后,分析多巴胺能神经元中诱导的细胞死亡和对l-多巴的响应性。我们证明多巴胺能神经元中dOTC的积累会引起神经变性和运动行为障碍,说明帕金森氏表型。这与左旋多巴反应性相关联,从而将该模型验证为PD模型。与野生型背景中的dOTC转基因相比,在PINK1 KO背景中dOTC过表达的组合转基因模型表现出增加的神经变性。而且,该组合模型没有显示出对左旋多巴的响应性。我们的体内数据表明,PINK1的丧失会加速由该细胞器中未折叠蛋白的表达触发的线粒体应激诱导的神经变性表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号